Company Filing History:
Years Active: 2021
Title: Meili Liu - Innovator in Medical Applications of CREG Protein
Introduction
Meili Liu is a prominent inventor based in Shenyang, China. She has made significant contributions to the field of medicine, particularly in the development of treatments for cardiovascular conditions. Her innovative work focuses on the medical use of the CREG protein, which has potential applications in preventing and treating various heart-related ailments.
Latest Patents
Meili Liu holds 1 patent related to her research. The patent is titled "Medical use of CREG protein." This invention pertains to the use of Cellular Repressor of E1A-stimulated Genes (CREG) in the manufacture of medicaments aimed at preventing and treating myocardial infarction. Additionally, it addresses ventricular remodeling after myocardial infarction and heart failure, as well as myocardial ischemia-reperfusion injury and salt-sensitive hypertensive myocardial fibrosis.
Career Highlights
Meili Liu is affiliated with the General Hospital of Chinese PLA Northern Theater Command. Her work at this institution has allowed her to focus on groundbreaking research that has the potential to improve patient outcomes in cardiovascular health.
Collaborations
Meili Liu collaborates with esteemed colleagues, including Yaling Han and Chenghui Yan. Their combined expertise enhances the research and development of innovative medical solutions.
Conclusion
Meili Liu's contributions to the medical field through her patent on CREG protein exemplify her dedication to advancing healthcare. Her work not only highlights her innovative spirit but also underscores the importance of collaboration in scientific research.